Results 171 to 180 of about 58,391 (264)

Resolving the renal microenvironment: a 5-plex immunofluorescence workflow to quantify B-lineage cells in FFPE lupus nephritis biopsies. [PDF]

Front Immunol
Chan C, Chang PS, Chalasani S, Tao J, Raghu H, Austin CD.   +5 more
europepmc   +1 more source

Patient Understanding of Multiple Myeloma and Communication Experiences (PUMMaCE): Results From a UK Survey

eJHaem, Volume 7, Issue 4, August 2026.
ABSTRACT Introduction Multiple myeloma (MM) is a complex haematological cancer. The terminology used can make discussions more challenging. We designed an online patient survey to explore this area. Methods Questions with fixed and free text response options explored understanding of MM and phrases Health Care Professionals (HCPs) and family used that ...
Valerie Jenkins, Rachel Hunter, Ruth Habibi, Shirley May, John Jones, Theresa Street, Clare Evans, Anna Cowley, Barbara Collinson, Helena Harder   +9 more
wiley   +1 more source

Characteristics, treatment regimens, and outcomes of patients with true extramedullary multiple myeloma: a real-world monocentric analysis. [PDF]

Ann Hematol
Harzer M, Gross-Fengels N, Melzer F, Molwitz I, Kosch R, Al-Bazaz M, Artzenroth J, Cords L, Bartke L, Kamili A, Alsdorf W, Bokemeyer C, Weisel K, Leypoldt LB, Schaefers C.   +14 more
europepmc   +1 more source

Real‐World Treatment Patterns and Physician Perspectives in Relapsed/Refractory Multiple Myeloma: Results From a Nationwide Italian GIMEMA Survey

eJHaem, Volume 7, Issue 4, August 2026.
ABSTRACT Background The management of relapsed/refractory multiple myeloma (RRMM) remains complex due to early exposure to multiple drug classes since the first treatment line. Aims To evaluate treatment patterns and identify unmet clinical needs in RRMM across Italian hematology centers.
Francesca Fazio, Alfonso Piciocchi, Paolo de Fabritiis, Messina Messina, Stefano Soddu, Valeria Sargentini, Francesco Di Raimondo, Francesca Patriarca, Pellegrino Musto, Maurizio Offidani, Elena Zamagni, Sara Bringhen, Massimo Gentile, Giuseppe Mele, Paola Fazi, MariaTeresa Petrucci, Michele Cavo   +16 more
wiley   +1 more source

Role of hypertrophic adipocytes, collagen VI, and CD38 in adipose tissue fibrosis in obesity. [PDF]

Sci Rep
Di Vincenzo A, Luca T, Perugini J, Lezoche G, Barresi V, De Geronimo V, Donati A, Casarotta E, Tomasello M, Pezzino S, Scuderi C, Di Cristoforo A, Pieroni A, Petrelli M, Napoli MV, Figueiredo N, Corgosinho FC, Sbarbati A, Merlini L, Sabatelli P, Graciotti L, Spadoni T, Dani C, Mattioli-Belmonte M, Condorelli DF, Gabrielli A, Malavasi F, Giordano A, Castorina S, Cinti S.   +29 more
europepmc   +1 more source

Efficacy and Safety of Daratumumab‐Based Regimens in Multiple Myeloma: A Systematic Review and Meta‐Analysis of Phase III Randomized Controlled Trials

eJHaem, Volume 7, Issue 4, August 2026.
ABSTRACT Introduction Multiple myeloma is a malignant plasma cell disorder predominantly affecting older adults and poses a significant health burden due to its incurable nature, high relapse rate, and associated immune dysfunction. Daratumumab, when added to standard therapy, has shown promising results in large trials.
Abdul Moiz Khan, Hafsa Ajmal, Muddassir Khalid, Waleed Babar, Usama Shafaqat, Tooba Fida, Mohammad Aitzaz Hassan, Sibgha Fatima, Ahmad Sameed Akram, Fred Segawa   +9 more
wiley   +1 more source

Emerging therapeutic advances for immune thrombocytopenia: highlights from selected early‑phase and pivotal trials at the 2025 ASH annual meeting. [PDF]

Exp Hematol Oncol
Cao L, Wang Z, Xiang Q.
europepmc   +1 more source

Infection Incidence and Survival in Patients With Multiple Myeloma and Chronic Lymphocytic Leukaemia: A Growing Concern in the Era of Modern Therapies

eJHaem, Volume 7, Issue 4, August 2026.
ABSTRACT Introduction Patients with multiple myeloma (MM) and chronic lymphocytic leukaemia (CLL) are burdened by immunodeficiency due to treatment and underlying disease. Infection‐related mortality remains a significant concern for patients' overall survival (OS). Methods This Swedish, population‐based study examined incidence of infections and OS in
Ingrid Glimelius, Love Tätting, Jonatan Freilich, M. Natalia Stelmaszuk, Qian Yang, Anna Deleskog, Sigurður Y. Kristinsson   +6 more
wiley   +1 more source

Safety and Effectiveness of Daratumumab in Recurrent and De Novo Focal Segmental Glomerulosclerosis After Kidney Transplant. [PDF]

Kidney Med
Mehta RV, Evans KB, Shah CV, Shukla A, Belal A, Ibrahim H, Alquadan K, Leghrouz M, Vrakas G, Mehta R, Santos A.   +10 more
europepmc   +1 more source

HCV‐Specific T‐Cell Recovery After a Year of SVR Following DAA Therapy

Journal of Medical Virology, Volume 98, Issue 8, August 2026.
ABSTRACT Direct‐acting antiviral (DAA) drugs lead to sustained virologic response (SVR) in almost all treated patients with chronic hepatitis C virus (HCV) infection. Despite this success, the long‐term effects of HCV clearance by DAA therapy on T‐cell‐mediated antiviral immunity remain unclear, particularly concerning the restoration of immune ...
Tetiana Pozniak, Salma Sharaf, Chloe Gross, Emade Ebah, Arshi Khanam, Amelia Cover, Ashley Davis, Shyam Kottilil, Poonam Mathur, Alip Ghosh   +9 more
wiley   +1 more source